STAT1 signaling in astrocytes is essential for control of infection in the central nervous system

mBio

Volumn 7, Issue 6, 2016, Pages

  Hidano, Shinya ^a,f   Randall, Louise M ^b   Dawson, Lucas ^a   Dietrich, Hans K ^c   Konradt, Christoph ^a   Klover, Peter J ^d   John, Beena ^a   Harris, Tajie H ^e   Fang, Qun ^a   Turek, Bradley ^a   Kobayashi, Takashi ^f   Hennighausen, Lothar ^d   Beiting, Daniel P ^a   Koshy, Anita A ^c   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

^f OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERFERON; STAT1 PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; EFFECTOR CELL; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION CONTROL; MOUSE; NONHUMAN; PARASITE PHENOMENA AND FUNCTIONS; PARASITE REPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TOXOPLASMIC ENCEPHALITIS; ANIMAL; ANIMAL TOXOPLASMOSIS; BRAIN; CELL CULTURE; DEFICIENCY; GENETICS; IMMUNOLOGY; METABOLISM; PARASITOLOGY; TOXOPLASMA;

ANIMALS; ASTROCYTES; BRAIN; CELLS, CULTURED; INTERFERON-GAMMA; MICE; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 85007524691     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01881-16     Document Type: Article

References (78)

1. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. 2006. CNS immune privilege: hiding in plain sight. Immunol Rev 213: 48-65. http:// dx.doi.org/10.1111/j.1600-065X.2006.00441.x.
2. Iadecola C, Nedergaard M. 2007. Glial regulation of the cerebral microvasculature. Nat Neurosci 10: 1369-1376. http://dx.doi.org/10.1038/ nn2003.
3. Dong Y, Benveniste EN. 2001. Immune function of astrocytes. Glia 36: 180-190. http://dx.doi.org/10.1002/glia.1107.
4. Sofroniew MV, Vinters HV. 2010. Astrocytes: biology and pathology. Acta Neuropathol 119: 7-35. http://dx.doi.org/10.1007/s00401-009-0619-8.
5. Wilson EH, Weninger W, Hunter CA. 2010. Trafficking of immune cells in the central nervous system. J Clin Invest 120: 1368-1379. http:// dx.doi.org/10.1172/JCI41911.
6. Strack A, Schlüter D, Asensio VC, Campbell IL, Deckert M. 2002. Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: impact of host genetic factors. Glia 40: 372-377. http://dx.doi.org/10.1002/glia.10104.
7. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-celldeficient hosts. Proc Natl Acad SciUSA90: 6115-6119. http://dx.doi.org/10.1073/pnas.90.13.6115.
8. Suzuki Y, Conley FK, Remington JS. 1989. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol 143: 2045-2050.
9. Halonen SK, Taylor GA, Weiss LM. 2001. Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun 69: 5573-5576. http://dx.doi.org/10.1128/IAI.69.9.5573-5576.2001.
10. Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, Howard JC. 2005. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog 1: e24. http:// dx.doi.org/10.1371/journal.ppat.0010024.
11. Halonen SK, Chiu F, Weiss LM. 1998. Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect Immun 66: 4989-4993.
12. Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima J, Sasai M, Kayama H, Okamoto T, Huang DC, Soldati-Favre D, Horie K, Takeda J, Takeda K. 2012. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii. Immunity 37: 302-313. http://dx.doi.org/10.1016/ J.Immuni.2012.06.009.
13. Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klümpers V, Lahme S, Wischmann E, Mausberg AK, Beer-Hammer S, Pfeffer K. 2013. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc Natl Acad Sci U S A 110: 294-299. http:// dx.doi.org/10.1073/pnas.1205635110.
14. Khan IA, MacLean JA, Lee FS, Casciotti L, DeHaan E, Schwartzman JD, Luster AD. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494. http:// dx.doi.org/10.1016/S1074-7613(00)80200-9.
15. Aviles H, Stiles J, O’Donnell P, Orshal J, Leid J, Sonnenfeld G, Monroy F. 2008. Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection. J Parasitol 94: 1282-1288. http:// dx.doi.org/10.1645/GE-1309.1.
16. Wen X, Kudo T, Payne L, Wang X, Rodgers L, Suzuki Y. 2010. Predominant interferon-γ-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis. J Interferon Cytokine Res 30: 653-660. http://dx.doi.org/10.1089/ jir.2009.0119.
17. + T cells. Nature 486: 545-548. http://dx.doi.org/10.1038/ nature11098.
18. Wilson EH, Hunter CA. 2004. The role of astrocytes in the immunopathogenesis of toxoplasmic encephalitis. Int J Parasitol 34: 543-548. http://dx.doi.org/10.1016/j.ijpara.2003.12.010.
19. Stenzel W, Soltek S, Schlüter D, Deckert M. 2004. The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis. J Neuropathol Exp Neurol 63: 631-640. http://dx.doi.org/10.1093/jnen/63.6.631.
20. Drögemüller K, Helmuth U, Brunn A, Sakowicz-Burkiewicz M, Gutmann DH, Mueller W, Deckert M, Schlüter D. 2008. Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J Immunol 181: 2683-2693. http://dx.doi.org/10.4049/jimmunol.181.4.2683.
21. Cekanaviciute E, Dietrich HK, Axtell RC, Williams AM, Egusquiza R, Wai KM, Koshy AA, Buckwalter MS. 2014. Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection. J Immunol 193: 139-149. http://dx.doi.org/10.4049/jimmunol.1303284.
22. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149: 175-180.
23. Gavrilescu LC, Butcher BA, Del Rio L, Taylor GA, Denkers EY. 2004. STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection. Infect Immun 72: 1257-1264. http://dx.doi.org/10.1128/IAI.72.3.1257-1264.2004.
24. Lieberman LA, Banica M, Reiner SL, Hunter CA. 2004. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J Immunol 172: 457-463. http://dx.doi.org/10.4049/jimmunol.172.1.457.
25. Lüder CG, Walter W, Beuerle B, Maeurer MJ, Gross U. 2001. Toxoplasma gondii down-regulatesMHCclass II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Eur J Immunol 31: 1475-1484. http://dx.doi.org/10.1002/1521-4141(200105)31: 5<1475:: AID-IMMU1475>3.0.CO;2-C.
26. γ induced gene expression and STAT1 phosphorylation. PLoS One 7: e51448. http://dx.doi.org/10.1371/journal.pone.0051448.
27. Zimmermann S, Murray PJ, Heeg K, Dalpke AH. 2006. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-γ signaling. J Immunol 176: 1840-1847. http://dx.doi.org/10.4049/jimmunol.176.3.1840.
28. Beiting DP, Hidano S, Baggs JE, Geskes JM, Fang Q, Wherry EJ, Hunter CA, Roos DS, Cherry S. 2015. The orphan nuclear receptor TLX is an enhancer of STAT1-mediated transcription and immunity to Toxoplasma gondii. PLoS Biol 13: e1002200. http://dx.doi.org/10.1371/journal .pbio.1002200.
29. Olias P, Etheridge RD, Zhang Y, Holtzman MJ, Sibley LD. 2016. Toxoplasma effector recruits the mi-2/NuRD complex to repress STAT1 transcription and block IFN-γ-dependent gene expression. Cell Host Microbe 20: 72-82. http://dx.doi.org/10.1016/j.chom.2016.06.006.
30. Gay G, Braun L, Brenier-Pinchart MP, Vollaire J, Josserand V, Bertini RL, Varesano A, Touquet B, De Bock PJ, Coute Y, Tardieux I, Bougdour A, Hakimi MA. 2016. Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-γ-mediated host defenses. J Exp Med 213: 1779-1798. http://dx.doi.org/10.1084/jem.20160340.
31. Schneider AG, Abi Abdallah DS, Butcher BA, Denkers EY. 2013. Toxoplasma gondii triggers phosphorylation and nuclear translocation of dendritic cell STAT1 while simultaneously blocking IFNγ-induced STAT1 transcriptional activity. PLoS One 8: e60215. http://dx.doi.org/10.1371/ journal.pone.0060215.
32. Lang C, Hildebrandt A, Brand F, Opitz L, Dihazi H, Lüder CG. 2012. Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ. PLoS Pathog 8: e1002483. http://dx.doi.org/10.1371/journal .ppat.1002483.
33. Zhuo L, Theis M, Alvarez-Maya I, Brenner M, Willecke K, Messing A. 2001. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31: 85-94. http://dx.doi.org/10.1002/gene.10008.
34. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A. 1994. GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14: 1030-1037.
35. Imura T, Nakano I, Kornblum HI, Sofroniew MV. 2006. Phenotypic and functional heterogeneity of GFAP-expressing cells in vitro: differential expression of LeX/CD15 by GFAP-expressing multipotent neural stem cells and non-neurogenic astrocytes. Glia 53: 277-293. http://dx.doi.org/10.1002/glia.20281.
36. Maubach G, Lim MC, Zhang CY, Zhuo L. 2006. GFAP promoter directs lacZ expression specifically in a rat hepatic stellate cell line. World J Gastroenterol 12: 723-730. http://dx.doi.org/10.3748/wjg.v12.i5.723.
37. + T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity 30: 300-311. http://dx.doi.org/10.1016/j.immuni .2008.12.013.
38. + T cells. J Immunol 185: 1502-1512. http://dx.doi.org/10.4049/jimmunol.0903450.
39. + dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35: 249-259. http://dx.doi.org/10.1016/j.immuni.2011.08.008.
40. Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY, Medzhitov R, Sher A. 2002. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol 168: 5997-6001. http:// dx.doi.org/10.4049/jimmunol.168.12.5997.
41. + T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii. Eur J Immunol 41: 3627-3631. http://dx.doi.org/10.1002/eji.20114187622002196.
42. Goldszmid RS, Caspar P, Rivollier A, White S, Dzutsev A, Hieny S, Kelsall B, Trinchieri G, Sher A. 2012. NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 36: 1047-1059. http:// dx.doi.org/10.1016/j.immuni.2012.03.026.
43. Cabral CM, Tuladhar S, Dietrich HK, Nguyen E, MacDonald WR, Trivedi T, Devineni A, Koshy AA. 2016. Neurons are the primary target cell for the brain-tropic intracellular parasite Toxoplasma gondii. PLoS Pathog 12: e1005447. http://dx.doi.org/10.1371/journal.ppat.1005447.
44. Scharton-Kersten TM, Yap G, Magram J, Sher A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185: 1261-1273. http://dx.doi.org/10.1084/jem.185.7.1261.
45. + T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29-37. http://dx.doi.org/10.1038/ ni.1679.
46. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8: 239-245. http://dx.doi.org/10.1038/ni1443.
47. + T cell exhaustion during chronic viral infection. Immunity 27: 670-684. http://dx.doi.org/10.1016/j.immuni.2007.09.006.
48. + T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci U S A 108: 9196-9201. http:// dx.doi.org/10.1073/Pnas.1015298108.
49. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D. 2010. Gene modulation and immunoregulatory roles of interferonγ. Cytokine 50: 1-14. http://dx.doi.org/10.1016/j.cyto.2009.11.021.
50. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, Gingeras TR, Gaasterland T, Schoolnik G, Nathan C. 2001. Reprogramming of the macrophage transcriptome in response to interferon-γ and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 194: 1123-1140. http://dx.doi.org/10.1084/jem.194.8.1123.
51. Carr DJ, Veress LA, Noisakran S, Campbell IL. 1998. Astrocyte-targeted expression of IFN-α1 protects mice from acute ocular herpes simplex virus type 1 infection. J Immunol 161: 4859-4865.
52. Campbell IL, Erta M, Lim SL, Frausto R, May U, Rose-John S, Scheller J, Hidalgo J. 2014. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J Neurosci 34: 2503-2513. http://dx.doi.org/10.1523/JNEUROSCI.2830-13.2014.
53. Bush TG, Puvanachandra N, Horner CH, Polito A, Ostenfeld T, Svendsen CN, Mucke L, Johnson MH, Sofroniew MV. 1999. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23: 297-308. http://dx.doi.org/10.1016/S0896-6273(00)80781-3.
54. Wanner IB, Anderson MA, Song B, Levine J, Fernandez A, Gray-Thompson Z, Ao Y, Sofroniew MV. 2013. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci 33: 12870-12886. http://dx.doi.org/10.1523/ JNEUROSCI.2121-13.2013.
55. Marino S, Vooijs M, van der Gulden H, Jonkers J, Berns A. 2000. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the Cerebellum. Genes Dev 14: 994-1004.
56. Theis M, Jauch R, Zhuo L, Speidel D, Wallraff A, Döring B, Frisch C, Söhl G, Teubner B, Euwens C, Huston J, Steinhäuser C, Messing A, Heinemann U, Willecke K. 2003. Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocytedirected inactivation of connexin 43. J Neurosci 23: 766-776.
57. Schlüter D, Deckert M, Hof H, Frei K. 2001. Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon-and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect Immun 69: 7889-7893. http://dx.doi.org/10.1128/IAI.69.12.7889-7893.2001.
58. Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, Seishima M. 2002. L-Tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect Immun 70: 779-786. http://dx.doi.org/10.1128/IAI.70.2.779-786.2002.
59. Silva NM, Rodrigues CV, Santoro MM, Reis LF, Alvarez-Leite JI, Gazzinelli RT. 2002. Expression of indoleamine 2,3-dioxygenase, trypto-phan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun 70: 859-868. http://dx.doi.org/10.1128/IAI.70.2.859-868.2002.
60. Yap GS, Sher A. 1999. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ-and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen, Toxoplasma gondii. J Exp Med 189: 1083-1092. http://dx.doi.org/10.1084/ jem.189.7.1083.
61. Melzer T, Duffy A, Weiss LM, Halonen SK. 2008. The gamma interferon (IFN-γ)-inducible GTP-binding protein IGTP is necessary for Toxoplasma vacuolar disruption and induces parasite egression in IFN-γ-stimulated astrocytes. Infect Immun 76: 4883-4894. http://dx.doi.org/10.1128/IAI.01288-07.
62. Mahamed DA, Mills JH, Egan CE, Denkers EY, Bynoe MS. 2012. CD73-generated adenosine facilitates Toxoplasma gondii differentiation to long-lived tissue cysts in the central nervous system. Proc Natl Acad Sci U S A 109: 16312-16317. http://dx.doi.org/10.1073/pnas.1205589109.
63. Jones TC, Bienz KA, Erb P. 1986. In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon. Infect Immun 51: 147-156.
64. +-T-cell effector function and migration following viral infection. J Virol 77: 4004-4014. http://dx.doi.org/10.1128/JVI.77.7.4004-4014.2003.
65. Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, Caspar P, Heiny S, Sher A. 1997. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159: 1903-1908.
66. Khan IA, Schwartzman JD, Matsuura T, Kasper LH. 1997. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci U S A 94: 13955-13960. http://dx.doi.org/10.1073/pnas.94.25.13955.
67. Yap GS, Scharton-Kersten T, Charest H, Sher A. 1998. Decreased resistance of TNF receptor p55-and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J Immunol 160: 1340-1345.
68. Deckert-Schlüter M, Bluethmann H, Rang A, Hof H, Schlüter D. 1998. Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J Immunol 160: 3427-3436.
69. Subauste CS, Wessendarp M. 2006. CD40 restrains in vivo growth of Toxoplasma gondii independently of gamma interferon. Infect Immun 74: 1573-1579. http://dx.doi.org/10.1128/IAI.74.3.1573-1579.2006.
70. Reichmann G, Walker W, Villegas EN, Craig L, Cai G, Alexander J, Hunter CA. 2000. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect Immun 68: 1312-1318. http://dx.doi.org/10.1128/IAI.68.3.1312-1318.2000.
71. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6: 2163-2178.
72. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. 2002. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87-90. http:// dx.doi.org/10.1038/nbt0102-87.
73. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, Carver-Moore K, DuBois RN, Clark R, Aguet M, Schreiber RD. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442. http://dx.doi.org/10.1016/S0092-8674(00)81288-X.
74. Klover PJ, Muller WJ, Robinson GW, Pfeiffer RM, Yamaji D, Hennighausen L. 2010. Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden. Neoplasia 12: 899-905. http://dx.doi.org/10.1593/neo.10716.
75. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA. 2005. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74. http://dx.doi.org/10.1016/j.jneuroim .2005.04.018.
76. Knoll LJ, Boothroyd JC. 1998. Isolation of developmentally regulated genes from Toxoplasma gondii by a gene trap with the positive and negative selectable marker hypoxanthine-xanthine-guanine phosphoribosyltransferase. Mol Cell Biol 18: 807-814. http://dx.doi.org/10.1128/MCB.18.2.807.
77. Reiner A, Yekutieli D, Benjamini Y. 2003. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375. http://dx.doi.org/10.1093/bioinformatics/btf877.
78. Beiting DP, Peixoto L, Akopyants NS, Beverley SM, Wherry EJ, Christian DA, Hunter CA, Brodsky IE, Roos DS. 2014. Differential induction of TLR3-dependent innate immune signaling by closely related parasite species. PLoS One 9: e88398. http://dx.doi.org/10.1371/journal.pone .0088398.